These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
522 related articles for article (PubMed ID: 30964573)
1. JAK/STAT pathway modulation: Does it work in dermatology? Gündüz Ö Dermatol Ther; 2019 May; 32(3):e12903. PubMed ID: 30964573 [TBL] [Abstract][Full Text] [Related]
2. An insight into JAK-STAT signalling in dermatology. Palanivel JA; Macbeth AE; Chetty NC; Levell NJ Clin Exp Dermatol; 2014 Jun; 39(4):513-8. PubMed ID: 24825142 [TBL] [Abstract][Full Text] [Related]
3. Targeting the Janus Kinase Family in Autoimmune Skin Diseases. Howell MD; Kuo FI; Smith PA Front Immunol; 2019; 10():2342. PubMed ID: 31649667 [TBL] [Abstract][Full Text] [Related]
4. JAK-STAT signaling pathway inhibition: a role for treatment of various dermatologic diseases. Kahn J; Deverapalli SC; Rosmarin D Semin Cutan Med Surg; 2018 Sep; 37(3):198-208. PubMed ID: 30215638 [TBL] [Abstract][Full Text] [Related]
5. Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions. Ryguła I; Pikiewicz W; Kaminiów K Molecules; 2023 Dec; 28(24):. PubMed ID: 38138551 [TBL] [Abstract][Full Text] [Related]
6. JAK inhibitor: Introduction. Raychaudhuri SP; Raychaudhuri SK Indian J Dermatol Venereol Leprol; 2023; 89(5):688-690. PubMed ID: 37609754 [TBL] [Abstract][Full Text] [Related]
7. JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects. Banerjee S; Biehl A; Gadina M; Hasni S; Schwartz DM Drugs; 2017 Apr; 77(5):521-546. PubMed ID: 28255960 [TBL] [Abstract][Full Text] [Related]
8. Targeting JAK/STAT signalling in inflammatory skin diseases with small molecule inhibitors. Welsch K; Holstein J; Laurence A; Ghoreschi K Eur J Immunol; 2017 Jul; 47(7):1096-1107. PubMed ID: 28555727 [TBL] [Abstract][Full Text] [Related]
9. JAK-STAT pathway inhibitors in dermatology. Miot HA; Criado PR; de Castro CCS; Ianhez M; Talhari C; Ramos PM An Bras Dermatol; 2023; 98(5):656-677. PubMed ID: 37230920 [TBL] [Abstract][Full Text] [Related]
10. Janus Kinase Inhibitors: A Review of Their Emerging Applications in Dermatology. Cinats A; Heck E; Robertson L Skin Therapy Lett; 2018 May; 23(3):5-9. PubMed ID: 29772037 [TBL] [Abstract][Full Text] [Related]
11. Janus Kinase Inhibitors in Dermatology: Part 2: Applications in Psoriasis, Atopic Dermatitis, and Other Dermatoses. Garcia-Melendo C; Cubiró X; Puig L Actas Dermosifiliogr (Engl Ed); 2021; 112(7):586-600. PubMed ID: 34030992 [TBL] [Abstract][Full Text] [Related]
12. JAK inhibitors in dermatology: The promise of a new drug class. Damsky W; King BA J Am Acad Dermatol; 2017 Apr; 76(4):736-744. PubMed ID: 28139263 [TBL] [Abstract][Full Text] [Related]
13. JAK inhibitors in dermatology: the road travelled and path ahead, a narrative review. Muddebihal A; Khurana A; Sardana K Expert Rev Clin Pharmacol; 2023 Apr; 16(4):279-295. PubMed ID: 36946306 [TBL] [Abstract][Full Text] [Related]
14. The JAK-STAT pathway: a therapeutic target in hematological malignancies. Ferrajoli A; Faderl S; Ravandi F; Estrov Z Curr Cancer Drug Targets; 2006 Dec; 6(8):671-9. PubMed ID: 17168672 [TBL] [Abstract][Full Text] [Related]
15. JAK-inhibitors in dermatology: current evidence and future applications. Ciechanowicz P; Rakowska A; Sikora M; Rudnicka L J Dermatolog Treat; 2019 Nov; 30(7):648-658. PubMed ID: 30433838 [TBL] [Abstract][Full Text] [Related]
16. Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature. Samadi A; Ahmad Nasrollahi S; Hashemi A; Nassiri Kashani M; Firooz A J Dermatolog Treat; 2017 Sep; 28(6):476-483. PubMed ID: 28024126 [TBL] [Abstract][Full Text] [Related]
18. The Specific Roles of JAK/STAT Signaling Pathway in Sepsis. Cai B; Cai JP; Luo YL; Chen C; Zhang S Inflammation; 2015 Aug; 38(4):1599-608. PubMed ID: 25676437 [TBL] [Abstract][Full Text] [Related]
19. Emerging therapeutic paradigms to target the dysregulated Janus kinase/signal transducer and activator of transcription pathway in hematological malignancies. Mughal TI; Girnius S; Rosen ST; Kumar S; Wiestner A; Abdel-Wahab O; Kiladjian JJ; Wilson WH; Van Etten RA Leuk Lymphoma; 2014 Sep; 55(9):1968-79. PubMed ID: 24206094 [TBL] [Abstract][Full Text] [Related]
20. [Research Advances of JAK/STAT Signaling Pathway in Lung Cancer]. Yang X; Tang Z; Zhang P; Zhang L Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):45-51. PubMed ID: 30674393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]